US Patent Issued to PHARMAEXCEED on Dec. 30 for "Nanoparticles for use in redirection against the tumour of a non-tumour specific immune response, based on a pre-existing immunity" (Italian Inventors)

ALEXANDRIA, Va., Dec. 31 -- United States Patent no. 12,508,310, issued on Dec. 30, was assigned to PHARMAEXCEED S.R.L. (Pavia, Italy).

"Nanoparticles for use in redirection against the tumour of a non-tumour specific immune response, based on a pre-existing immunity" was invented by Gilberto Filaci (Genoa, Italy), Daniela Fenoglio (Genoa, Italy), Francesca Ferrera (Genoa, Italy), Maria Luisa Torre (Pavia, Italy), Elia Bari (San Nazzaro Val Cavargna, Italy) and Sara Perteghella (Cura Carpignano, Italy).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present patent application relates to nanoparticles for the delivery and targeting of a non-tumour-specific antigen in cancer cells, comprising a matrix suppor...